Accuracy (high pressure drug)

2022: Withdrawal of the drug

At the end of March 2022, Pfizer recalls several blood pressure drugs due to increased nitrosamine, which can increase the risk of cancer.

Pfizer said it voluntarily withdraws six batches of Accuracy tablets that the company distributed, one batch of quinapril and hydrochlorothiazide tablets and four batches of quinapril hydrochlorothiazide tablets, because the nitrosamine level exceeded the permissible daily norm. Nitrosamines are often found in water and food, including dried and fried meat, dairy products and vegetables, Pfizer said in a recall notice.

Pfizer recalls high-pressure drug due to cancer-causing carcinogens

The company reported that Pfizer is not aware of reports of undesirable events estimated to be related to this recall. According to the nationwide daily USA Today, increased nitrosamine content can increase the risk of cancer if people are exposed to them above acceptable levels for a long time.

Experts health care USA advise patients to consult with their doctors or pharmacists before stopping taking one of the recalled blood pressure drugs or finding an alternative treatment. Stopping taking the recalled drug can cause more immediate harm than continuing to take. Patients with the recalled drug can call 888-843-0247 on weekdays from 8:00 a.m. to 5:00 p.m. Eastern Time and receive instructions for returning the drug and reimbursing its cost.

Drug recall 90-gram blood pressure vials:

• Aquaretic (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg

NDC: 0071-3112-23; Batch number: FG5379; Shelf life: August 2024.
NDC: 0071-0222-23; Lot number: EA6686; April 2022.

• Aquaretic (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg

NDC: 0071-5212-23; Batch number: FG5381; Shelf life: August 2024.
NDC: 0071-0220-23; Lot number: EA6665; Shelf life: April 2022.
NDC: 0071-0220-23; Lot number: CN0640; Expiration date: April 2022.

• Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg

NDC: 0071-0223-23; Batch number: ET6974; Expiration date: February 2023.

• Quinapril and hydrochlorothiazide tablets, 20/25 mg:

NDC: 59762-5225-9; Lot number: FE3714; Expiration date: February 2023.

• Quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg:

NDC: 59762-0220-1; Lot number: DN6931; Expiration date: March 2023.
NDC: 59762-0220-1; Lot number: ED3904; Shelf life: March 2023.
NDC: 59762-0220-1; Lot number: ED3905; Expiration date: March 2023.

• Quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

NDC: 59762-5225-9; Batch number: FE3714; Expiration date: February 2023.^[1]

Notes